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Abstract
Background: Antimicrobial resistance has been declared by the World Health Organization as a threat to the public
health. The aim of this study was to analyze antimicrobial resistance patterns of the common pathogens occurring at
the Bugando Medical Centre (BMC), Mwanza, Tanzania to provide data for antimicrobial stewardship programmes.
Methods: A total of 3330 microbiological culture results scripts representing non-repetitive specimens reported between
June 2013 and May 2015 were retrieved and analyzed for pathogens and their susceptibility patterns using STATA-11
software.
Results: Out of 3330 specimens, 439 (13.2%) had positive culture. Staphylococcus aureus (n = 100; 22.8%), Klebsiella
pneumoniae (n = 65; 14.8%) and Escherichia coli (n = 41; 9.3%) were the most frequently isolated bacteria. Of 78
Staphylococcus aureus tested, 27 (34.6%) were found to be methicillin resistant Staphylococcus aureus (MRSA).
Rates of resistance of Klebsiella pneumoniae and Escherichia coli isolates to third generation cephalosporins were
38.5% (25/65) and 29.3% (12/41) respectively. Staphylococcus aureus and Klesbiella pneumoniae were commonly
isolated from bloodstream infections while Escherichia coli and Pseudomonas aeruginosa were the predominant
isolates from urinary tract and wounds infections respectively. Of 23 Salmonella species isolated, 22 (95%) were
recovered from the blood. Nine of the 23 Salmonella species isolates (39%) were found to be resistant to third
generation cephalosporins. The resistance rate of gram-negative bacteria to third generation cephalosporins
increased from 26.5% in 2014 to 57.9% in 2015 (p = 0.004) while the rate of MRSA decreased from 41.2% in 2013
to 9.5% in 2015 (p = 0.016). Multidrug-resistant gram-negative isolates were commonly isolated from Intensive
Care Units and it was noted that, the majority of invasive infections were due to gram-negative bacteria.
Conclusion: There is an increase in proportion of gram-negative isolates resistant to third generation cephalosporins.
The diversity of potential pathogens resistant to commonly prescribed antibiotics underscores the importance of
sustained and standardized antimicrobial resistance surveillance and antibiotic stewardship programmes in developing
countries.
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Background
Antimicrobial resistance (AMR) has reached a critical
point and is now becoming a global threat to the public
health worldwide. The World Health Organization (WHO)
has declared AMR a public health threat and has urged
different countries to develop action plan to combat the
problem [1]. Knowledge on the epidemiology of healthcare-
associated infections (HCAIs) and the antimicrobial suscep-
tibility patterns of the isolates are crucial towards guiding
empirical treatment [2]. The spectra of bacteria causing
infections and their susceptibility pattern have been found
to vary from one setting to another; a fact which highlights
the importance of having local surveillance data for plan-
ning and implementing infection prevention and control
(IPC) measures [3–5]. High income countries including the
United States, have managed to decrease the burden of
HCAIs by 30% through effective implementation surveil-
lance systems [6]. A study which was conducted in a teach-
ing hospital in Nigeria, showed the reduction of HCAIs
rates from 5.8 to 2.8% in 2003 and 2006 respectively
through the implementation of an effective infection
control program [7]. In fighting emerging infections,
surveillance data regarding AMR in Europe have been
made available starting at regional to international
levels via databases to ease communication between
scientists [2, 8]. In Africa there are limited surveil-
lance data irrespective of an upsurge of HCAIs and
AMR clones circulating both in hospitals and communities
[9–11]. At the BMC hospital in Tanzania the rate of ex-
tended spectrum beta-lactamases (ESBL) producing
Escherichia coli increased from 25 to 50%, and that of
MRSA increased from 16 to 44% between 2009 and
2014 [12–14]. Preliminary findings show significant vari-
ation of the epidemiology and evolution of these strains as
evidenced by multiple clones of Escherichia coli carrying
blaCTX-M-15 [15], causing sepsis among neonates and a new
ST1797 MRSA causing wound infections [16]. Infections
due to multidrug-resistant isolates have been found to
be associated with increased morbidity and mortality
[17, 18]. The emerging of these multidrug-resistant clones
coupled with the introduction of expensive and last resort
antibiotics such as carbapenems and vancomycin pose a
great challenge in combating AMR at BMC and in develop-
ing countries at large. This analysis was done to assess the
pattern of bacterial isolates and their susceptibility patterns
from various specimens received at BMC microbiological
laboratory between June 2013 and May 2015. These data
are crucial in rationalizing empirical treatment and set
measures for IPC, surveillance and policy change in
Tanzania and in other developing countries.
Methods
Between June 2013 and May 2015 a retrospective analysis
of BMC microbiological culture results was done. BMC is a
tertiary, consultant and teaching hospital located in
Northwestern Tanzania. It serves a population of about
13 million people from eight regions. A total of 3387
laboratory culture results were retrieved during the
observational period. Out of 3387 laboratory results,
87 scripts were excluded from the analysis due to in-
complete filling of the microbiological laboratory form.
Missing particulars included age, clinical history, anti-
biotic use, specimen type and ward number.
Microbiological analysis
BMC clinical microbiology laboratory is accredited
according to ISO 15189 by Southern African Development
Community Accreditation Service (SADCAS) accreditation
body with registration number MD 002. It participates in
bacteriology external quality assurance coordinated by a
reference laboratory in South Africa (WHO/NICD).
Clinicians were responsible for decisions regarding taking
specimens for microbiological culture based on the clinical
assessment of the patients. Specimens were processed
following the BMC microbiology laboratory standard
operating procedures (SOPs). Contaminants were defined
as isolated bacteria that were more likely to be normal flora
depending on the type and site where the specimen was
taken. Identification of bacteria was carried out by
conventional biochemical methods [19]. In case of ambigu-
ity, analytical profile index (API) 20E or 20NE (bioMérieux,
France) was used to confirm identification. Antimicrobial
susceptibility testing was performed using the disk-dif-
fusion method and interpreted according to the Clinical
Laboratory Standards Institute guidelines (CLSI) [20].
Gram-negative bacteria resistant to either ceftriaxone
(30 μg) or cefotaxime (30 μg) or both were termed as
resistant to third generation cephalosporins. Intermediate
susceptibility results were regarded as resistant in the ana-
lysis. MRSA was detected using cefoxitin (30 μg) disk and
the isolate with zone of inhibition of ≤ 21 mm was con-
firmed phenotypically to be MRSA.
Quality control
During the observation period, Staphylococcus aureus
ATCC 25923, Escherichia coli ATCC 25922 and Klebsiella
pneumoniae ATCC 13883 were used as quality control
strains. In addition, in-house molecular typed MRSA
strain and Escherichia coli ATCC 35218 were also
used as positive controls for MRSA and third gener-
ation cephalosporin resistant organisms respectively.
Data analysis
In the analysis of these data, children were defined as ≤
12 years old and adults > 12 years old according to BMC
admission criteria. Types of infections analyzed included;
blood stream (sepsis, bacteremia), pneumonia, urinary
tract, upper respiratory tract, surgical site, skin and soft
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tissue (abscess, pyoderma, pyomyositis, ulcer and wound),
gastro-intestinal, central nervous system and cardiovascular
system [21].
All demographic and clinical data as indicated in BMC
microbiological request/report form were extracted and
entered in Excel spreadsheet. Data were analyzed using
STATA version 11 (STATA Corp LP, USA). Categorical
variables were summarized as proportions and were ana-
lyzed using the Pearson’s Chi-Square test or Fisher’s exact
to test statistical differences among the various groups.
Odds ratios with their respective 95% confidence interval
(CI) were calculated to measure the strength of associa-




During the study period (June 2013 to May 2015), a total
of 3330 non-repetitive specimens were analyzed; blood
2238 (67.2%), urine 307 (9.2%), cerebrospinal fluid 303
(9.1%), pus swabs 206 (6.2%), aspirates 148 (4.4%),
sputum 86 (2.6%) and stool 42 (1.3%). Of the analyzed
specimens, 971 (29.2%), 1888 (56.7%) and 471 (14.1%)
were from year 2013, 2014 and 2015 respectively. The
paediatric population contributed 67% (651/971), 47.9%
(904/1888) and 74.7% (352/471) of the total specimens
analyzed in 2013, 2014 and 2015 respectively.
Culture results
Out of 3330 specimens processed during the observation
period, 439 (13.2%) were found to be culture positive
and 140 (4.2%) had contamination. Contamination rates
were significantly more in pediatric wards than in other
wards (106/1907; 5.6% vs. 34/1393; 2.4%, p < 0.001).
Positive culture rates were 17.8% (173/971), 11.8% (223/
1888) and 9.1% (43/471) in 2013, 2014 and 2015
respectively.
Antibiotic use before specimen collection
Out of 3330 microbiological request/report forms, 1257
(37.8%) reported the patients to have had an exposure to
antibiotics before the specimens were taken. Types of
antibiotics documented were penicillins (22.2%, n = 279),
gentamicin (16.15%, n = 203), ceftriaxone or cefotaxime
(16.1%, n = 202), meropenem (0.9%, n = 12), ciprofloxacin
(2.2%, n = 28) and unspecified (58.6%, n = 736).
Pathogens and their susceptibility pattern
Out of 439 positive cultures, most frequently isolated
pathogens were Staphylococcus aureus (22.8%, n = 100),
Klebsiella pneumoniae (14.8%, n = 65) and Escherichia
coli (9.3%, n = 41) Table 1. Majority of Staphylococcus
aureus (61%, n = 61) and Klebsiella pneumoniae (70.8%,
n = 46) isolates were from paediatric population (Paediatric,
PREM/NICU and PICU) while the majority of Escherichia
coli isolates (68.3%, n = 28) were from adults (Table 2).
Staphylococcus aureus and Klebsiella pneumoniae were the
most frequent isolates recovered from blood (3.6%, n = 80/
2238 and 1.9%, n = 42/2238, Table 1). Escherichia coli (7.2%;
n = 22/307) dominated the urinary tract infections.
Of 41 Escherichia coli isolates, 19 were tested for the
susceptibility to third generation cephalosporins of which,
12 (63.2%) were found to be resistant. Out of 22 Escherichia
coli isolates from urinary tract infections, 20 (90.9%) were
susceptible to nitrofurantoin. Twenty four Escherichia coli
isolates were tested for the susceptibility to ciprofloxacin;
16 (66.7%) were found to be resistant. Regarding 65
Klebsiella pneumoniae isolated, 31 were tested for the
Table 1 Bacterial isolates distribution by specimens
Pathogen CSF Blood Urine Aspirates Pus swabs Sputum Stool Total
n = 303 (%) n = 2238(%) n = 307(%) n = 148 (%) n = 206(%) n = 86(%) n = 42(%) n = 3330(%)
Candida species. 0 (0) 0 (0) 1 (0.33) 0 (0) 12 (5.8) 0 (0) 0 (0) 13
Citrobacter species. 0 (0) 11 (0.5) 4 (1.3) 0 (0) 9 (4.4) 3 (3.48) 0 (0) 27
Escherichia coli 1 (0.33) 9 (0.4) 22 (7.2) 0 (0) 8 (3.9) 1 (1.16) 0 (0) 41
Klebsiella pneumoniae 1 (0.33) 42 (1.9) 15 (4.9) 0 (0) 3 (1.45) 4 (4.65) 0 (0) 65
Other gram-positivea 0 (0) 4 (0.2) 3 (0.9) 0 (0) 1 (0.5) 0 (0) 0 (0) 8
Other gram-negativeb 1 (0.33) 54 (2.4) 35 (11.4) 1 (0.67) 24 (11.65) 14 (16.3) 3 (7.14) 132
Pseudomonas aeruginosa 0 (0) 5 (0.22) 2 (0.7) 0 (0) 14 (6.8) 3 (3.48) 0 (0) 24
Staphylococcus aureus 0 (0) 80 (3.6) 1 (0.33) 0 (0) 18 (8.7) 1 (1.16) 0 (0) 100
Salmonella species. 0 (0) 22 (0.9) 0 (0) 0 (0) 1 (0.48) 0 (0) 0 (0) 23
Streptococcus species. 1 (0.33) 4 (0.2) 1 (0.33) 0 (0) 0 (0) 0 (0) 0 (0) 6
Total 4 (1.32) 231 (10.32) 84 (27.39) 1 (0.67) 90 (43.68) 26 (30.23) 3 (7.14) 439 (13.2)
aOther gram-positive: Enterococcus species. n = 7 and Staphylococcus saprohyticus n = 1
bOther gram-negative: Unidentified n = 106, Enterobacter species. n = 12, Proteus mirabilis n = 6, Proteus vulgaris n = 4, Shigella species. n = 4
CSF cerebrospinal fluid
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susceptibility to third generation cephalosporins of
which, 25 (80.6%) were found to be resistant whereas of
61 Klebsiella pneumoniae isolates tested for gentamicin,
51 (83.6%) were found to be resistant. All 48 Klebsiella
pneumoniae isolates tested for the susceptibility to imi-
penem were found to be susceptible.
The proportion of Salmonella species among positive
cultures was 5.2% (n = 23/439) of which 95.7% were from
blood (n = 22), Table 1. The majority of Salmonella species
(82.6%, n = 19) were isolated from paediatric wards
(Table 2). Out of 23 Salmonella species, 16 were tested
for the susceptibility to third generation cephalosporins of
which, 9(56.3%) were found to be resistant. All 15 Sal-
monella species tested against ciprofloxacin were found
to be susceptible.
Most of the Pseudomonas aeruginosa isolates (58.3%,
n = 14/24) were recovered from wound swabs. Of 24
Pseudomonas aeruginosa isolates, 16 were tested for the
susceptibility to the third generation cephalosporins of
which, 14(87.5%) were found to be resistant. A total of
20/22 (90.9%) Pseudomonas aeruginosa were found to
be susceptible to amikacin.
Methicillin-resistant Staphylococcus aureus (MRSA) trend
Out of 100 Staphylococcus aureus isolates, 78 isolates
were tested for cefoxitin of which, 27 (34.6%) were found
to be MRSA. Of 27 MRSA isolates, 62.9% (n = 17) were
from the paediatric population. The MRSA proportion
kept on fluctuating during the observation period; it was
41.2% (n = 14/34), 47.8% (n = 11/23) and 9.5% (n = 2/21)
in 2013, 2014 and 2015 respectively (p = 0.016). MRSA
isolates were significantly more isolated from sterile parts
of the body (blood, aspirates and cerebrospinal fluid) than
from non-sterile (urine, pus and wound swabs) (32.5 vs.
5%; p = 0.01) (Fig. 1).
Resistance to third generation cephalosporins
The overall proportion of gram-negative bacteria resistant
to third generation cephalosporins was 35.9% (112/312).
The majority (59.8%, n = 67/112) of these isolates were
from children. When distributed by years of the observation,
the isolation trend was 44.9% (n = 57/127), 26.5% (n = 44/
166) and 57.9% (n = 11/19) in 2013, 2014 and 2015 respect-
ively. The gram-negative bacteria resistant to third gener-
ation cephalosporins proportion was significantly higher in
isolates from Intensive Care Units (ICUs) (46.9%) than in
other wards (31.8%); OR= 1.89, 95% CI (1.1–3.3), p= 0.01.
In addition, the isolation rate of the gram-negative bacteria
resistant to third generation cephalosporins was higher from
Table 2 Bacterial isolates distribution by wards/units
Pathogen Surgery Paediatric Medical EMD AICU PREM/NICU PICU Total
n = 425 (%) n = 1403 (%) n = 790 (%) n = 95 (%) n = 113 (%) n = 425 (%) n = 79 (%) n = 3330
Candida species. 9 (2.1) 0 (0) 0 (0) 3 (3.2) 0 (0) 0 (0) 1 (1.27) 13
Citrobacter species. 10 (2.4) 3 (0.2) 7 (0.9) 0 (0) 1 (0.9) 5 (1.2) 1 (1.27) 27
Escherichia coli 9 (2.1) 11 (0.7) 13 (1.7) 5 (5.3) 1 (0.9) 2 (0.5) 0 (0) 41
Klebsiella pneumoniae 5 (1.2) 18 (1.3) 12 (1.5) 2 (2.1) 0 (0) 28 (6.6) 0 (0) 65
Other gram-positivea 0 (0) 3 (0.2) 0 (0) 3 (3.2) 0 (0) 1 (0.2) 1 (1.27) 8
Other gram-negativeb 33 (7.8) 31 (2.2) 25 (3.2) 6 (6.3) 6 (5.3) 29 (6.8) 2 (2.5) 132
Pseudomonas aeruginosa 7 (1.7) 4 (0.3) 7 (0.9) 1 (1.1) 1 (0.9) 4 (0.9) 0 (0) 24
Staphylococcus aureus 17 (4) 36 (2.6) 16 (2.0) 2 (2.1) 4 (3.5) 24 (5.7) 1 (1.27) 100
Salmonella species. 1 (0.2) 17 (1.2) 2 (0.3) 0 (0) 1 (0.9) 1 (0.2) 1 (1.27) 23
Streptococcus species. 0 (0) 3 (0.2) 0 (0) 1 (1.1) 0 (0) 2 (0.5) 0 (0) 6
Total 91 (21.5) 126 (8.9) 82 (10.5) 23 (24.4) 14 (12.4) 96 (22.6) 7 (8.9) 439
PREM premature unit, AICU adult ICU, NICU neonatal ICU, PICU paediatric ICU, EMD emergency medicine department
aOther gram-positive: Enterococcus species. n = 7 and Staphylococcus saprohyticus n = 1
bOther gram-negative: Unidentified n = 106, Enterobacter species. n = 12, Proteus mirabilis n = 6, Proteus vulgaris n = 4, Shigella species. n = 4
Fig. 1 Third generation cephalosporins-resistant (3GC-R) gram negative
bacteria and MRSA isolation from non-sterile Vs sterile body sites
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sterile sites (41.5%) than non-sterile sites (30.9%), p = 0.051
(Fig. 1).
Discussion
In the present analysis, a total of 3387 specimens that
were sent for culture and sensitivity between June 2013
and May 2015, the number seem to be little in a
hospital with a bed capacity of 900. Relying on the
National or local treatment guidelines which emphasize
more on empirical treatment might have contributed
to low number of specimens received in the laboratory
[22]. Deployment and adherence to antimicrobial ther-
apy guidelines and policies using evidence-based gen-
erated data might improve the current situation as
previously shown in Botswana [23]. Blood specimens
contributed to more than half of specimens processed
and the majority were from paediatric wards. This
could be explained by the local practice in these wards
that emphasize on the need of blood culture to all chil-
dren presenting with fever.
In the present analysis, Staphylococcus aureus and
Klebsiella pneumoniae were the predominant organisms
causing bloodstream infections from pediatric wards.
These findings are in agreement with a prospective study
which was conducted at a national hospital in Tanzania
among neonates with fever which found Staphylococcus
aureus to be the predominant pathogen (54.5%) followed
by Klesbiella pneumoniae (32.7%) [24]. Similar findings
were observed at BMC in 2010 [12], indicating the per-
sistence of pattern in pediatric wards especially in neo-
natal units.
With regard to urinary tract infections in this analysis,
Escherichia coli was found to be the most frequently
isolated pathogen. A similar finding was observed in
previous studies done in the same setting [25, 26].
Escherichia coli isolates from urine demonstrated high
rates of resistance to ciprofloxacin and third generation
cephalosporins than to nitrofurantoin. The rate of re-
sistance of nitrofurantoin has remained low all years in
the present study. Despite being cheap, this antibiotic is
not commonly self-prescribed. Ciprofloxacin and third
generation cephalosporins are commonly used at BMC
than nitrofurantoin and they are also commonly self-
prescribed in the community. The overuse of ciproflox-
acin and cephalosporins might be the most probable
cause of higher resistance rates observed.
As in previous study [27], the majority of Salmonella
species isolates were isolated from blood in this study
and all of the tested Salmonella species isolates were
susceptible to ciprofloxacin. This finding is similar to a
study done in Ghana, which observed Salmonella typhi
to be the most prevalent pathogen isolated from blood-
stream infection and all isolates were susceptible to cipro-
floxacin [27]. The observation of 100% susceptibility of
Salmonella species isolates to ciprofloxacin in our setting
could be explained by the non-use of this antimicrobial
agent in paediatric wards. This can be evidenced by the fact
that the majority of these isolates were from the paediatric
wards. This is further supported by the previous study
which observed 8% of Salmonella species isolates from
adults to be resistant to ciprofloxacin [28]. In this study, a
significant proportion of Salmonella species isolates were
resistant to third generation cephalosporins. Similar
findings have been observed in Europe from people
who travelled from Asian countries [29, 30] and in Kenya
[31]. However, these findings are in contrast with the previ-
ous study conducted three years ago in the same hospital
which observed all Salmonella species to be susceptible to
ceftriaxone [28]; suggesting the presence of emerging
multidrug-resistant Salmonella species in Northwestern
Tanzania.
As in previous study [14], most of the Pseudomonas
aeruginosa isolates in this study were recovered from
wound swabs and more than 50% were resistant to third
generation cephalosporins. The majority of Pseudomonas
aeruginosa isolates in this study were sensitive to amikacin,
as previously observed [32]. This could be explained by the
rare use this aminoglycoside in our setting and other setting
in low and middle-income countries.
The general proportion of MRSA in this study was found
to be in agreement with MRSA proportion observed in
other studies done in the same setting in 2010 and 2014
[12, 14]. However, during the observation period a signifi-
cant decrease was observed in 2015, this could be explained
by the ongoing hand washing campaigns and improvement
of IPC programs in various BMC wards coupled by in-
creased awareness of the emergence of multidrug-resistant
strains among healthcare workers. The latter measures have
been shown to reduce MRSA outbreaks [33]. In the present
study, MRSA isolates were significantly found to cause in-
vasive infections. Invasive MRSA infections might lead to
increased morbidity and mortality of the infected patients
as previously observed [12].
Although the overall trend of the proportions of gram-
negative bacteria resistant to third generation cephalo-
sporins appeared to decrease in 2014 in comparison to
2013, the significant upsurge of these notorious strains
was observed in 2015. The high resistance rates ob-
served in ICU patients could be explained by the fact
that patients in ICU tend to stay longer in the hospital
and this has been found to increase risk infections due
to multidrug-resistant pathogens [34].
Conclusions
The observed high proportion of gram-negative isolates
being resistant to third generation cephalosporins is
alarming and calls for a surveillance of HCAIs and
community infections to establish the source and
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transmission pathways. The emergence of Salmonella spe-
cies isolates resistant to third generation cephalosporins is
worrisome because of increased infections of Salmonella
species observed in HIV infected patients which is en-
demic in low-income countries.
Despite the good service offered by BMC microbiology
laboratory shortcomings have been observed which need
rectifications. Monitoring and proper screening of isolates
resistant to third generation cephalosporins to know the
mechanisms of resistance responsible should be done.
Consistency in antimicrobials tested for the isolates should
be observed to establish a homogeneous database.
Adherence to CLSI guidelines in processing microbio-
logical isolates should be mandatory. It is a high time
to consider having the local antimicrobial guide using
local generated data to guide treatment. There is need
to perform molecular characterization of common isolates
involved in HCAIs in developing countries so that evi-
dence based data can be used to improve the IPC in
our setting.
Study limitations
The analysis based on getting information from micro-
biological request/report forms therefore it was difficult
to tell whether the infection originated from the com-
munity or it was healthcare-associated. Antimicrobial
susceptibility testing depended on the availability of anti-
microbial discs at that particular time. This has resulted
to inconsistent bacterial antibiogram patterns and diffi-
culties in reporting resistance rates of the most frequent
isolates. Antimicrobial agents were tested against wrong
isolates as per CLSI guidelines e.g. ceftriaxone was tested
against Pseudomonas aeruginosa isolates. Moreover, specific
tests like inducible clindamycin resistance (D-test) and
ESBL testing were not done. Other important epidemio-
logical information such as patient’s outcome, duration of
hospital stay etc. were not reported. Lastly, there might be
sampling bias in this analysis because there were no guide-
lines for systematic specimen collection for microbiological
culture.
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